Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Case Report

Published on 25 Apr 2022

Facial Palsy as Initial Symptom in Glycine Receptor Antibody Positive Progressive Encephalomyelitis With Rigidity and Myoclonus: A Case Report

in Multiple Sclerosis and Neuroimmunology

Li Wang
Rui Zhang
Kai Liu
Yafang Xu
Bo Song
Yuming Xu

Frontiers in Neurology

doi 10.3389/fneur.2022.866183

2,452 views
2 citations

Review

Published on 15 Apr 2022

Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review

in Multiple Sclerosis and Neuroimmunology

Fioravante Capone
Angela Albanese
Giorgia Quadri
Vincenzo Di Lazzaro
Emma Falato
Antonio Cortese
Laura De Giglio
Elisabetta Ferraro

Frontiers in Neurology

doi 10.3389/fneur.2022.851413

11,050 views
17 citations

Review

Published on 15 Apr 2022

Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?

in Multiple Sclerosis and Neuroimmunology

Massimiliano Mirabella
Pietro Annovazzi
Wallace Brownlee
Jeffrey A. Cohen
Christoph Kleinschnitz
Christian Wolf

Frontiers in Neurology

doi 10.3389/fneur.2022.844873

7,392 views
10 citations

Case Report

Published on 14 Apr 2022

The First Case of Familiar Anti-leucine-rich Glioma-Inactivated1 Autoimmune Encephalitis: A Case Report and Literature Review

in Multiple Sclerosis and Neuroimmunology

Chuhan Ding
Qibing Sun
Ran Li
Hanli Li
Yu Wang

Frontiers in Neurology

doi 10.3389/fneur.2022.855383

2,515 views
2 citations

Original Research

Published on 14 Apr 2022

Relatively Early and Late-Onset Neuromyelitis Optica Spectrum Disorder in Central China: Clinical Characteristics and Prognostic Features

in Multiple Sclerosis and Neuroimmunology

Jinbei Yu
Shuai Yan
Pengpeng Niu
Junfang Teng

Frontiers in Neurology

doi 10.3389/fneur.2022.859276

3,043 views
6 citations

Original Research

Published on 14 Apr 2022

Influential Factors, Treatment and Prognosis of Autoimmune Encephalitis Patients With Poor Response to Short-Term First-Line Treatment

in Multiple Sclerosis and Neuroimmunology

Fei Liu
Bingbing Zhang
Teng Huang
Baojie Wang
Chunjuan Wang
Maolin Hao
Shougang Guo

Frontiers in Neurology

doi 10.3389/fneur.2022.861988

3,676 views
4 citations

Original Research

Published on 14 Apr 2022

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Ruth Ann Marrie
John D. Fisk
Randy Walld
James M. Bolton
Jitender Sareen
Scott B. Patten
Alexander Singer
Lisa M. Lix
Carol A. Hitchon
Renée El-Gabalawy

Frontiers in Neurology

doi 10.3389/fneur.2022.874724

6,486 views
6 citations

Original Research

Published on 12 Apr 2022

Long-Term Prognosis of Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Who Underwent Teratoma Removal: An Observational Study

in Multiple Sclerosis and Neuroimmunology

Hesheng Zhang
Weixi Xiong
Xu Liu
Wenyu Liu
Dong Zhou
Xintong Wu

Frontiers in Neurology

doi 10.3389/fneur.2022.874867

4,136 views
7 citations

Original Research

Published on 07 Apr 2022

Effects of a 6-Min Treadmill Walking Test on Dual-Task Gait Performance and Prefrontal Hemodynamics in People With Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Kim-Charline Broscheid
Martin Behrens
Christian Dettmers
Michael Jöbges
Lutz Schega

Frontiers in Neurology

doi 10.3389/fneur.2022.822952

3,816 views
7 citations

Case Report

Published on 06 Apr 2022

Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports

in Multiple Sclerosis and Neuroimmunology

Enrico Belgrado
Ilaria Del Negro
Daniele Bagatto
Simone Lorenzut
Giovanni Merlino
Gian L. Gigli
Mariarosaria Valente

Frontiers in Neurology

doi 10.3389/fneur.2022.817295

2,674 views
3 citations

Original Research

Published on 06 Apr 2022

Clinical Profile and Treatment Outcome in MOGAD: A Single-Center Case-Series Study in Guiyang, China

in Multiple Sclerosis and Neuroimmunology

Xiaoyang Lei
Shipeng Guo
Shengnan Cui
Yin Pu
Anni Zhang
Dian He

Frontiers in Neurology

doi 10.3389/fneur.2022.830488

6,642 views
4 citations

Mini Review

Published on 31 Mar 2022

Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure

in Multiple Sclerosis and Neuroimmunology

Navid Manouchehri
Victor H. Salinas
Negar Rabi Yeganeh
David Pitt
Rehana Z. Hussain
Olaf Stuve

Frontiers in Neurology

doi 10.3389/fneur.2022.854390

5,369 views
16 citations

Original Research

Published on 29 Mar 2022

Incidence of Developmental Venous Anomalies in Patients With Multiple Sclerosis: A 3 Tesla MRI Study

in Multiple Sclerosis and Neuroimmunology

Marton Magyar
Thomas Gattringer
Christian Enzinger
Eva Hassler
Richard Partl
Michael Khalil
Gernot Reishofer
Hannes Deutschmann
Franz Fazekas

Frontiers in Neurology

doi 10.3389/fneur.2022.824347

2,842 views

Study Protocol

Published on 28 Mar 2022

Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study

in Multiple Sclerosis and Neuroimmunology

Ed Waddingham
Aleisha Miller
Ruth Dobson
Paul M. Matthews

Frontiers in Neurology

doi 10.3389/fneur.2022.799531

3,294 views

Original Research

Published on 24 Mar 2022

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course

in Multiple Sclerosis and Neuroimmunology

Ariel Rechtman
Livnat Brill
Omri Zveik
Benjamin Uliel
Nitzan Haham
Atira S. Bick
Netta Levin
Adi Vaknin-Dembinsky

Frontiers in Neurology

doi 10.3389/fneur.2022.867190

4,527 views
23 citations

Review

Published on 23 Mar 2022

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease

in Multiple Sclerosis and Neuroimmunology

Alessandro Dinoto
Elia Sechi
Eoin P. Flanagan
Sergio Ferrari
Paolo Solla
Sara Mariotto
John J. Chen

Frontiers in Neurology

doi 10.3389/fneur.2022.866824

15,545 views
25 citations